H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 141 Citations 92,353 532 World Ranking 622 National Ranking 371

Research.com Recognitions

Awards & Achievements

2020 - Member of the National Academy of Sciences

2014 - Fellow of the American Academy of Arts and Sciences

2014 - Fellow, National Academy of Inventors

2009 - Member of the National Academy of Medicine (NAM)

2009 - Paul Marks Prize for Cancer Research, Memorial Sloan Kettering Cancer Center

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

The scientist’s investigation covers issues in Prostate cancer, Cancer research, Cancer, TMPRSS2 and Prostate. Arul M. Chinnaiyan interconnects Fusion gene, Transcriptional Regulator ERG and Pathology in the investigation of issues within Prostate cancer. His Cancer research study incorporates themes from Bioinformatics, Molecular biology, Metastasis, Androgen receptor and ETS transcription factor family.

The various areas that Arul M. Chinnaiyan examines in his Cancer study include Immunology, Gene, Oncology and Disease. His work carried out in the field of TMPRSS2 brings together such families of science as Transmembrane Protease Serine 2, Chromoplexy, ETV1, Fluorescence in situ hybridization and TMPRSS2 Gene. The study incorporates disciplines such as PTEN, Aurora inhibitor and Cancer biomarkers in addition to Prostate.

His most cited work include:

  • Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer (3179 citations)
  • FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex (2847 citations)
  • FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis (2270 citations)

What are the main themes of his work throughout his whole career to date?

Arul M. Chinnaiyan spends much of his time researching Prostate cancer, Cancer research, Cancer, Internal medicine and Oncology. His Prostate cancer study combines topics in areas such as TMPRSS2, Prostate and Pathology. His TMPRSS2 study integrates concerns from other disciplines, such as Transcriptional Regulator ERG, Chromoplexy and ETV1.

His study explores the link between Cancer research and topics such as Fusion gene that cross with problems in Molecular biology. His Cancer research includes themes of Computational biology, Immunology and Bioinformatics. His research in Internal medicine is mostly focused on Disease.

He most often published in these fields:

  • Prostate cancer (42.76%)
  • Cancer research (41.45%)
  • Cancer (29.50%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cancer research (41.45%)
  • Prostate cancer (42.76%)
  • Cancer (29.50%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Cancer research, Prostate cancer, Cancer, Internal medicine and Oncology. Arul M. Chinnaiyan combines subjects such as Wnt signaling pathway, Carcinogenesis, KRAS, Epigenetics and Immunotherapy with his study of Cancer research. His Prostate cancer research is multidisciplinary, incorporating elements of Prostate, Metastasis and Cancer biomarkers.

He mostly deals with Breast cancer in his studies of Cancer. As part of one scientific family, Arul M. Chinnaiyan deals mainly with the area of Internal medicine, narrowing it down to issues related to the Transcriptome, and often Computational biology and Exome. Arul M. Chinnaiyan studied Oncology and Biomarker that intersect with Pathology.

Between 2017 and 2021, his most popular works were:

  • The Landscape of Circular RNA in Cancer. (368 citations)
  • The long tail of oncogenic drivers in prostate cancer (290 citations)
  • CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy (246 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

His primary scientific interests are in Cancer research, Prostate cancer, Cancer, Transcriptome and Androgen receptor. His Cancer research study combines topics from a wide range of disciplines, such as Carcinogenesis, T cell, Immunotherapy, Cancer immunotherapy and Epigenetics. His study in Prostate cancer is interdisciplinary in nature, drawing from both Prostate, Metastasis and Oncology.

His Cancer research integrates issues from Exome sequencing, Exome, Clinical record, General surgery and Surgical oncology. His research integrates issues of Computational biology and DNA sequencing in his study of Transcriptome. His Androgen receptor research incorporates themes from TMPRSS2, Cell, Androgen and Regulation of gene expression.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer

S.A. Tomlins;D.R. Rhodes;S. Perner;S.M. Dhanasekaran.
Science (2005)

4241 Citations

FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex

Marta Muzio;Arul M. Chinnaiyan;Frank C. Kischkel;Karen O'Rourke.
Cell (1996)

3745 Citations

FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis

Arul M. Chinnaiyan;Karen O'Rourke;Muneesh Tewari;Vishva M. Dixit.
Cell (1995)

3208 Citations

ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform

Daniel R. Rhodes;Jianjun Yu;K. Shanker;Nandan Deshpande.
Neoplasia (2004)

2830 Citations

The polycomb group protein EZH2 is involved in progression of prostate cancer

Sooryanarayana Varambally;Saravana M. Dhanasekaran;Ming Zhou;Terrence R. Barrette.
Nature (2002)

2829 Citations

Integrative clinical genomics of advanced prostate cancer

Dan Robinson;Eliezer M. Van Allen;Eliezer M. Van Allen;Yi Mi Wu;Nikolaus Schultz.
Cell (2015)

2261 Citations

The Receptor for the Cytotoxic Ligand TRAIL

Guohua Pan;Karen O'Rourke;Arul M. Chinnaiyan;Reiner Gentz.
Science (1997)

2256 Citations

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

Bin Zhao;Xiaomu Wei;Weiquan Li;Ryan S. Udan;Ryan S. Udan.
Genes & Development (2007)

2251 Citations

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

Arun Sreekumar;Laila M. Poisson;Thekkelnaycke M. Rajendiran;Amjad P. Khan.
Nature (2009)

2117 Citations

The mutational landscape of lethal castration-resistant prostate cancer

Catherine S. Grasso;Yi Mi Wu;Dan R. Robinson;Xuhong Cao.
Nature (2012)

2034 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Arul M. Chinnaiyan

Mark A. Rubin

Mark A. Rubin

University of Bern

Publications: 296

Peter S. Nelson

Peter S. Nelson

Fred Hutchinson Cancer Research Center

Publications: 183

Johann S. de Bono

Johann S. de Bono

Institute of Cancer Research

Publications: 170

Massimo Loda

Massimo Loda

Cornell University

Publications: 148

Martin E. Gleave

Martin E. Gleave

University of British Columbia

Publications: 146

Francesca Demichelis

Francesca Demichelis

University of Trento

Publications: 130

Kenneth J. Pienta

Kenneth J. Pienta

Johns Hopkins University School of Medicine

Publications: 116

Himisha Beltran

Himisha Beltran

Harvard University

Publications: 115

Ronald Simon

Ronald Simon

Universität Hamburg

Publications: 113

Yuzhuo Wang

Yuzhuo Wang

University of British Columbia

Publications: 111

William B. Isaacs

William B. Isaacs

Johns Hopkins University

Publications: 111

Angelo M. De Marzo

Angelo M. De Marzo

Johns Hopkins University School of Medicine

Publications: 108

Liang Cheng

Liang Cheng

Indiana University

Publications: 104

Andrea Sboner

Andrea Sboner

Cornell University

Publications: 104

William C. Hahn

William C. Hahn

Harvard University

Publications: 103

Philip W. Kantoff

Philip W. Kantoff

Memorial Sloan Kettering Cancer Center

Publications: 99

Something went wrong. Please try again later.